Enough COVID Vaccines for World Population Says IFPMA: Calls for…
Pharma industry leaders have called for rich nations to stop stockpiling excess COVID-19 vaccine doses and stated that there will be enough production…
Tagged with J&J
Chronic Disease: A Gathering Storm in Singapore
Singapore is one of the healthiest countries in Asia with a life expectancy in excess of 82 years buttressed by one of the most robust healthcare…
Africa’s Biggest Pharma Company Gets $700 million for Vaccine…
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government institutions from the USA, Germany, and…
Michael Hübner – New Venture Lead, Johnson & Johnson…
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide, forming collaborations between entrepreneurs and the…
Germany Pharma News: Merck KGaA Expecting More COVID-Related…
The latest news from German pharma, including a new US leadership team and more COVID-related investment at Merck KGaA; the CureVac vaccine’s role…
Top 10 Pharma Companies in Canada Ranking 2020
The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the top spot with USD 3.46 billion,…
Guillermo Frydman – Managing Director, J&J Singapore
J&J Singapore's Guillermo Frydman outlines how his affiliate negotiated the COVID-19 pandemic; why managing J&J's pharma, medical devices,…
Top 20 Companies for Access to Medicine 2021
The Top 20 companies on the 2021 Access to Medicines Index ranked on governance of access, research and development, and product delivery indices.…
Filip Standaert – Managing Director Nordics, Johnson &…
Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe, how the affiliate responded to the…
South Africa’s Aspen Inks Deal to Manufacture J&J’s…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed commercial manufacture of their COVID-19…
Spain Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest developments at Spanish firm PharmaMar…
J&J’s Momenta Deal A Further Sign of Big Pharma’s Rare…
In the wake of Sanofi’s USD 3.7 billion tie-up for US biotech Principia, J&J has moved to bolster its autoimmune portfolio with the acquisition…
